Georgetown, Guyana – Midway Specialty Care Center
The Ministry of Public Health and PAHO/WHO would like to inform the general public that the National Public Health Reference Laboratory (NPHRL) is solely authorized to test for the Novel Coronavirus (COVID-19).
This facility also is the only one in Guyana with the capacity to perform the approved test. Any suspected case should be tested using available molecular test at the NPHRL. The NPHRL provides the specific procedures for collection of samples and can also request for testing to be done.
Suspected cases can fall within three categories. These categories specifically includes patient with acute respiratory illness , travel history to country reporting local transmission, persons who have been in contact with confirm cases among other clinic outlines prompting a test.s, Director of the local laboratory said Saturday.
For up to date information on COVID-19 and actions taken to combat the disease in Guyana please follow the link below or call the hotlines.
Raja Talati, MD received his medical degree from Ross University School of Medicine and completed an Internship and Residency at Jackson Park Hospital in Chicago, IL in Family Medicine. Dr. Talati, MD serves as the Assistant Chief Medical Officer of Midway Specialty Care Center, Inc. in Florida. He is involved with the development of the telemedicine program so that patients with limited access to specialty care would be better served. He sees patients at Midway Primary Care Center in Fort Pierce as well as the Midway Primary Care, LLC in Okeechobee.
For his country he currently holds the position of Chief of Aerospace Medicine for the 927th AMDS at MacDill Air Force Base. He has about 400 hours of flight time in the C-17 an KC-135.
Since completing medical school, he earned his Masters In Health Information Systems and is pursuing his MBA with a specialization in Healthcare Analytics.
When not working; he enjoys outdoor activities and traveling with his family.
Dr Anthony has practiced medicine in Guyana since 1993. After graduating from the Braun School of Public Health, he became the executive director of the Health Sector Development Unit, which was responsible for the reorganizing of the health sector in Guyana. Dr Anthony also served as the Project Manager for the World Bank-funded program on HIV Prevention and Control Program; Inter American Development Bank-funded Basic Nutrition Program, Health Sector Development Program, Health Sector Policy and Institutional Development Grant. He was the Project Manager of the Global Fund Grant on HIV, TB and Malaria.
Dr Frank Anthony is a parliamentarian with more than twelve years. His interest is in making laws relating to public health, food safety, human rights, child protection, youth, sports and culture. Dr Anthony was Guyana’s minister of Culture, Youth and Sports (2006 to 2015).
Dr Anthony is in clinical practice and teaches at the University of Guyana as an AdjunctProfessor in Public Health. He also consults for several organizations in the area of public health. Dr Anthony has been elected as a Member of the Guyana Medical Council and was recently appointed as PANCAP’s Champion of Change for his work on HIV/AIDS in the Caribbean.
We are honored that Dr. Anthony has joined forces with Midway Specialty Care Center for an International endeavor in Guyana. He is the project manager as we focus on establishing a viable office to expand the scope of services available to the residents of Guyana living with HIV or other infectious diseases.
|Total population (2016)||773,000|
|Gross national income per capita (PPP international $, 2013)||6,550|
|Life expectancy at birth m/f (years, 2016)||64/69|
|Probability of dying under five (per 1 000 live births, 2017)||31|
|Probability of dying between 15 and 60 years m/f (per 1 000 population, 2016)||313/210|
|Total expenditure on health per capita (Intl $, 2014)||379|
|Total expenditure on health as % of GDP (2014)||5.2|
According to the World Health Organization, the country is in epidemiological transition. The non-communicable diseases are major causes of morbidity and mortality. In 2012, based on the Pan America Health Organization (PAHO) Mortality Data, non-communicable diseases accounted for the first five leading causes of death. Violence and injuries and intentional self-harm also contribute significantly to the mortality rate. There is still a significant burden of communicable diseases. Human Immunodeficiency Virus, influenza and pneumonia were the sixth and ninth leading causes of death respectively in 2012. Data from the Ministry of Public Health (MoPH) show a reduction in the incidence of malaria and filaria in 2015; however, in 2015 the incidence of HIV was higher than in 2014 and tuberculosis incidence increased from 73/100.000 in 2014 to 75/100,000 in 2015. There is a very successful immunization programme and trained health personnel attend nearly all births. A progress report on the MDGs in 2011 indicated that the following targets had been met: halving the proportion of people suffering from hunger; education, gender equality; reducing the under 5 mortality rate by two-thirds; combating HIV/AIDS, malaria and other diseases; environmental stability and water and sanitation.
See latest data: https://www.paho.org/salud-en-las-americas-2017/?p=2635
HIV Statistics: https://pancap.org/pancap-data/guyana/
The Agency rationalizes public health arrangements in the Region by combining the functions of five Caribbean Regional Health Institutes (RHIs) into a single agency. CARICOM consists of: Antigua and Barbuda, Barbados, Belize, Dominica, Grenada, Guyana, Haiti, Jamaica, Montserrat, St. Kitts and Nevis, Saint Lucia, St. Vincent and the Grenadines, Trinidad and Tobago.
See Latest country-by-country HIV breakdown: https://pancap.org/data-reports/country-data/
HIV Health data:
A new Caribbean Regional Strategic Framework on HIV and AIDS 2014-2018 (CRSF III) was developed. The Strategic Framework was prepared following wide-ranging consultation and extensive document review. CRSF III supports a regional health vision that includes the AIDS response, and which allows partner countries to capitalize on the investments already made, including cross-cutting and interdependent areas. It includes a set of top-line priorities and strategic actions that are tied to measurable outcomes. CRSF III also encapsulates strategies to address the challenges, needs and priorities identified by countries.
The programme includes the roll out of a Justice for All Roadmap which is aligned to the following four key elements: i) Increasing access to treatment including affordable medicines; ii) Reducing gender inequality including violence against women, girls and children; iii) Promoting sexual and reproductive health and rights, in the context of self-worth; and iv) Achieving legislative reforms for modifying and repealing discriminatory laws that infringe human rights.